Can Atelectasis Be Prevented With Oxygen Reserve Index (ORI) Monitoring?
Launched by ANTALYA TRAINING AND RESEARCH HOSPITAL · Jul 1, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a special monitor called the Oxygen Reserve Index (ORI) during surgery can help prevent a common lung problem called atelectasis, where parts of the lung collapse after the operation. The researchers will look at adult patients having planned robotic surgeries under general anesthesia that last more than two hours. They will use lung ultrasound, a painless imaging method, to check the lungs after surgery and see if ORI monitoring makes a difference.
To take part, patients need to be generally healthy enough for surgery (classified as ASA I-III), be scheduled for elective robotic surgery lasting over two hours, and require a small tube in an artery for monitoring during the operation. People with severe health issues, low oxygen levels before surgery, chronic lung diseases, blood disorders, pregnancy, or those who do not want to participate will not be eligible. If you join, your care team will use the ORI monitor during your surgery to help manage your oxygen levels more precisely, with the goal of reducing lung complications afterward. This study is not yet recruiting participants but aims to improve safety and recovery for patients undergoing these types of surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists Physical Status Classification System (ASA) physical status I-III
- • Elective robotic surgery under general anesthesia
- • Surgery duration \>2 hours
- • Requires invasive arterial cannulation
- • Signed informed consent
- Exclusion Criteria:
- • ASA IV or higher
- • Room air SpO₂ \<92%
- • Chronic pulmonary disease
- • Hemoglobinopathy
- • Pregnancy
- • Refusal to participate
About Antalya Training And Research Hospital
Antalya Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Antalya, Turkey, the hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals committed to conducting rigorous and ethical research. With a focus on enhancing treatment outcomes and contributing to medical knowledge, Antalya Training and Research Hospital collaborates with various stakeholders to support the development of new therapies and interventions across a range of medical disciplines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antalya, Muratpasa, Turkey
Patients applied
Trial Officials
NILGUN KAVRUT OZTURK, PROFESSOR MD
Study Chair
Antalya Training and Research Hospital
AYSE MERVE ERDEM, RESIDENT
Principal Investigator
Antalya Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported